Pre-treatment circulating cytokines predict toxicity with combination anti-PD1 and anti-CTLA4 immunotherapy

被引：0

作者：

Lee, J. H. ^{[1
]}

Lim, S. Y. ^{[2
]}

Menzies, A. M. ^{[3
,4
]}

Carlino, M. S. ^{[5
]}

Guminski, A. ^{[3
,4
]}

Nahar, K. ^{[6
]}

Palmieri, D. ^{[7
]}

Breen, E. ^{[2
]}

Kefford, R. ^{[8
,9
]}

Scolyer, R. ^{[10
]}

Long, G. V. ^{[3
,4
]}

Rizos, H. ^{[1
]}

机构：

[1] Macquarie Univ, Melanoma Inst Australia, Biomed Sci, Sydney, NSW, Australia

[2] Macquarie Univ, Biomed Sci, Sydney, NSW, Australia

[3] Univ Sydney, Royal North Shore Hosp, Melanoma Inst Australia, Dept Med Oncol, Sydney, NSW, Australia

[4] Univ Sydney, Mater Hosp, Melanoma Inst Australia, Dept Med Oncol, Sydney, NSW, Australia

[5] Univ Sydney, Melanoma Inst Australia, Crown Princess Mary Canc Ctr, Med Oncol, Westmead, NSW, Australia

[6] Univ Sydney, Melanoma Inst Australia, Med Oncol, Sydney, NSW, Australia

[7] Crown Princess Mary Canc Ctr, Med Oncol, Westmead, NSW, Australia

[8] Macquarie Univ, Clin Med, Sydney, NSW, Australia

[9] Univ Sydney, Westmead Hosp, Melanoma Inst Australia, Sydney, NSW, Australia

[10] Univ Sydney, Melanoma Inst Australia, Royal Prince Alfred Hosp, Pathol, Camperdown, NSW, Australia

来源：

基金：

英国医学研究理事会;

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1861P

引用

页码：659 / 659

页数：1